Metered Dose Inhaler |
|
|
Clinical Trial: Comparative effectiveness of a breath-operated albuterol inhaler in asthma patients with poor inhaler technique
This study has been completed.
|
Purpose
This study is designed to examine the effectiveness of a breath-operated albuterol inhaler in asthma patients who have difficulty using their standard "press-and-breathe" inhaler.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Asthma | Drug: Albuterol | Phase II |
MedlinePlus related topics: Asthma
Study Type: Interventional
Study Design: Treatment
Study start: March 2003
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Stable asthma
- Poor inhaler coordination technique.
Exclusion Criteria:
- Requires beta-blockers, MAO inhibitors, tricyclic antidepressants, long-acting beta-blockers, steroids other than those inhaled
Location Information
Colorado
National Jewish Medical and Research Center, Denver, Colorado, 80206, United States
More Information
Record last reviewed: July 2003
Last Updated: October 13, 2004
Record first received: February 14, 2003
ClinicalTrials.gov Identifier: NCT00054964
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- A MDI and Inspirease Spacer (Cleveland Clinic)
- Metered Dose Inhaler (Cleveland Clinic)

Not Signed In -

